查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
婦產科系癌症的全球市場(2022年～2028年)
市場調查報告書
商品編碼
1078185

婦產科系癌症的全球市場(2022年～2028年)

Global Gynecological Cancers Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

全球婦產科系癌症的市場規模，在預測期間內預計以17.3％大幅度的年複合成長率成長。

本報告提供全球婦產科系癌症市場相關調查分析，市場概要，競爭情形，市場區隔分析，地區分析等資訊。

目錄

第1章 報告摘要

第2章 市場概要與考察

  • 調查範圍
  • 分析師的考察和目前市場趨勢

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 主要策略分析
  • COVID-19對主要企業的影響

第4章 市場區隔

  • 全球婦產科系癌症市場:各類型
    • 子宮頸部
    • 卵巢
    • 子宮
    • 陰道
    • 外陰部
    • 其他(輸卵管癌症)
  • 全球婦產科系癌症市場:各診斷
    • 山口浦項鋼鐵P
    • 生物檢驗
    • 人類乳突病毒(HPV)檢驗
    • 影像檢查
    • 其他(骨盆檢驗)
  • 全球婦產科系癌症市場:各治療法
    • 化療
    • 放射線治療
    • 荷爾蒙療法
    • 免疫療法
  • 全球婦產科系癌症市場:各終端用戶
    • 醫院、外科中心
    • 診斷中心
    • 其他(研究機關)

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他的亞太地區
  • 其他地區

第6章 企業簡介

  • Abbott Laboratories, Inc.
  • AstraZeneca, PLC
  • Becton, Dickinson and Co.
  • Boehringer Ingelheim GmbH
  • Bristol Myers Squibb Co.
  • Caris Life Sciences, Inc.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche, Ltd.
  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Hologic, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Kazia Therapeutics, Ltd.
  • Merck & Co., Inc.
  • NuCana PLC
  • Pfizer, Inc.
  • Sanofi S.A.
  • Siemens Healthcare GmbH
  • Takeda Pharmaceuticals Co., Ltd.
  • Teva Pharmaceuticals, Ltd.
Product Code: OMR2019501

Global Gynecological cancers Market Size, Share & Trends Analysis Report By Type (Cervical Cancer, Ovarian Cancer, Uterine Cancer, Vaginal Cancer, Vulvar Cancer, and Others (Fallopian Tube Cancer)) By Diagnosis (Colposcopy, Biopsy test Human papillomavirus (HPV) tests, Imaging test) By Therapeutic Modality (Chemotherapy, Radiation Therapy, Hormonal Therapy, Immunotherapy) By End-User (Hospitals and Surgical Centres, Diagnostic Centres, and Others (Research Institutions) Forecast 2022-2028

The global gynecological cancersmarket is anticipated to grow at a substantial CAGR of 17.3% during the forecast period.Gynecologic cancers begin in different places within a woman's pelvis, which is the area below the stomach and in between the hip bones.Each gynecologic cancer is unique, with different signs and symptoms, different risk factors. The different types of gynecologic cancer are cervical cancer, ovarian cancer, uterine cancer, vaginal cancer, and vulvar cancer. Most of the cervical cancer is caused by human papillomavirus (HPV).The growth of the market in the North America is mainly determined by a huge number of R&D activities; financial aids by governments, other private and non-private organizations; collaborations within pharmaceuticals and technology companies and regulatory policies in the country. For instance, according to the American Cancer Society (ACS) in September 2020 updated the guidelines for cervical cancer screening for early detection of cervical cancer. Thus, such active involvement organization is anticipated to support the market growth. Besides this, according to WHO, Cervical Cancer Country Profiles, 2021, the age-standardized cervical cancer incidence rate per 100 000 women in 2020 is estimated to be 6.2.

The global gynecological cancers market is segmented based on type, diagnosis, therapeutic modality and end-users. Based on type the market is segmented into cervical cancer, ovarian cancer, uterine cancer, vaginal cancer, vulvar cancer, and others. Based on diagnosis the market is bifurcated into Colposcopy, Biopsy test Human papillomavirus (HPV) tests, Imaging test . Based on Therapeutic Modality the market is sub-segmented into Chemotherapy, Radiation Therapy, Hormonal Therapy, Immunotherapy. Based on end-user the market is sub-segmented into Hospitals and Surgical Centres, Diagnostic Centres, and Others.Based on the end-user Tthe diagnostic segment is anticipated to grow at the fastest rate, as diagnostic centersis the place where the patients can have proper diagnosis related to cancer and can take medical assistance under observation ofand get experienced healthcare professionalsand high-quality material and equipment. . Also, the increasing number of cancer patients along with growing awareness regarding the various benefits and facilities provided in diagnostics centres is considered a prime factor that isare supporting the growth of the diagnosticsegment.

Geographically market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.North America dominates the market and is expected to continue its presence over the forecast period. The growth can be attributed to the increasing number of ovarian cancer patients andrising obesity in the North America are the main factors supporting the market growth. The obese people are more likely to get cancer compare to healthy person. According to Trust for America's Health, The US adult obesity rate tops 40 %, which is recorded highest.Obesity has serious health consequences including increased risk for type 2 diabetes, high blood pressure, stroke and many types of cancers. Obesity is assessed to increase healthcare spending by $149 billion annually.These factors are significantly increasing the pace of the global gynecological cancer market and diagnosis equipment also.

The major companies serving the global gynecological cancersmarket are Siemens Healthcare GmbH, Pfizer, Inc.andothers. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance,

Research Methodology

The market study of the global gynecological cancersmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, researchpapers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Gynecological cancersMarket Research and Analysis by Type

2. Global Gynecological cancersMarket Research and Analysis by Diagnosis

3. Global Gynecological cancersMarket Research and Analysis by TherapeuticModality

4. Global Gynecological cancersMarket Research and Analysis by End-User

The Report Covers

  • Comprehensive research methodology of the globalgynecological cancermarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global gynecological cancersmarket.
  • Insights about market determinants that are stimulating the global gynecological cancersmarket.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

Category-Healthcare

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the GlobalGynecological cancersMarket
  • Recovery Scenario of GlobalGynecological cancersMarket
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key CompanyAnalysis
    • 3.1.1. Overview
    • 3.1.2. Financial Ananlysis
    • 3.1.3. SWOT Ananlysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. GlobalGynecological CancersMarket, by Type
    • 4.1.1. Cervical
    • 4.1.2. Ovarian
    • 4.1.3. Uterine
    • 4.1.4. Vaginal
    • 4.1.5. Vulvar
    • 4.1.6. Others (Fallopian Tube Cancer)
  • 4.2. Global Gynecological CancersMarket, by Diagnosis
    • 4.2.1. Colposcopy
    • 4.2.2. Biopsy test
    • 4.2.3. Human papillomavirus (HPV) tests
    • 4.2.4. Imaging test
    • 4.2.5. Others (Pelvic Test)
  • 4.3. Global Gynecological Cancers Market, byTherapeutic Modality
    • 4.3.1. Chemotherapy
    • 4.3.2. Radiation Therapy
    • 4.3.3. Hormonal Therapy
    • 4.3.4. Immunotherapy
  • 4.4. Global Gynecological cancers Market, by End-user
    • 4.4.1. Hospitals and Surgical Centres
    • 4.4.2. Diagnostic Centres
    • 4.4.3. Others (Research Institutions)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories, Inc.
  • 6.2. AstraZeneca, PLC
  • 6.3. Becton, Dickinson and Co.
  • 6.4. Boehringer Ingelheim GmbH
  • 6.5. Bristol Myers Squibb Co.
  • 6.6. Caris Life Sciences, Inc.
  • 6.7. Eli Lilly and Co.
  • 6.8. F. Hoffmann-La Roche, Ltd.
  • 6.9. Genentech, Inc.
  • 6.10. GlaxoSmithKline PLC
  • 6.11. Hologic, Inc.
  • 6.12. Janssen Pharmaceuticals, Inc.
  • 6.13. Kazia Therapeutics, Ltd.
  • 6.14. Merck & Co., Inc.
  • 6.15. NuCana PLC
  • 6.16. Pfizer, Inc.
  • 6.17. Sanofi S.A.
  • 6.18. Siemens Healthcare GmbH
  • 6.19. Takeda Pharmaceuticals Co., Ltd.
  • 6.20. Teva Pharmaceuticals, Ltd.

LIST OF TABLES

1. GLOBAL GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028($ MILLIONS)

  • 2. GLOBAL GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028($ MILLION)
  • 3. GLOBAL CERVICAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 4. GLOBAL OVARIAN CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 5. GLOBAL UTERINE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 6. GLOBAL VAGINAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 7. GLOBAL VULVAR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 8. GLOBAL OTHER GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 9. GLOBAL GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028($ MILLION)
  • 10. GLOBAL COLPOSCOPY IN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 11. GLOBAL BIOPSY TEST IN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 12. GLOBAL IMAGING TEST IN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 13. GLOBAL HUMAN PAPILLOMAVIRUS TESTS IN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 14. GLOBAL OTHER GYNECOLOGICAL CANCER DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 15. GLOBAL GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS, BY THERAPEUTIC MODALITY 2021-2028($ MILLION)
  • 16. GLOBAL CHEMOTHERAPY FOR GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS, 2021-2028($ MILLION)
  • 17. GLOBAL RADIATION THERAPY FOR GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS, 2021-2028($ MILLION)
  • 18. GLOBAL HORMONAL THERAPY FOR GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS, 2021-2028($ MILLION)
  • 19. GLOBAL IMMUNOTHERAPY FOR GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS, 2021-2028($ MILLION)
  • 20. GLOBAL GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
  • 21. GLOBAL GYNECOLOGICAL CANCER IN HOSPITALS AND SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS, 2021-2028($ MILLION)
  • 22. GLOBAL GYNECOLOGICAL CANCER IN DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS, 2021-2028($ MILLION)
  • 23. GLOBAL OTHERS GYNECOLOGICAL CANCER END-USERS MARKET RESEARCH AND ANALYSIS, 2021-2028($ MILLION)
  • 24. NORTH AMERICAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2021-2028($ MILLION)
  • 25. NORTH AMERICAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028($ MILLION)
  • 26. NORTH AMERICAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC MODALITY, 2021-2028($ MILLION)
  • 27. NORTH AMERICAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
  • 28. NORTH AMERICAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
  • 29. EUROPEAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2021-2028($ MILLION)
  • 30. EUROPEAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028($ MILLION)
  • 31. EUROPEAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC MODALITY, 2021-2028($ MILLION)
  • 32. EUROPEAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
  • 33. EUROPEAN GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
  • 34. ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2021-2028($ MILLION)
  • 35. ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028($ MILLION)
  • 36. ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC MODALITY, 2021-2028($ MILLION)
  • 37. ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
  • 38. ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
  • 39. REST OF THE WORLD GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2021-2028($ MILLION)
  • 40. REST OF THE WORLD GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028($ MILLION)
  • 41. REST OF THE WORLD GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC MODALITY, 2021-2028($ MILLION)
  • 42. REST OF THE WORLD GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL CRYONICS TECHNOLOGY MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL CRYONICS TECHNOLOGY MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL CRYONICS TECHNOLOGY MARKET, 2021-2028 (%)
  • 4. GLOBAL GYNECOLOGICAL CANCER MARKET SHARE BY CANCER TYPE, 2021-2028(%)
  • 5. GLOBAL GYNECOLOGICAL CANCER MARKET SHARE BY DIAGNOSIS, 2021-2028(%)
  • 6. GLOBAL GYNECOLOGICAL CANCER MARKET SHARE BY THERAPEUTIC MODALITY, 2021-2028(%)
  • 7. GLOBAL GYNECOLOGICAL CANCER MARKET SHARE BY END-USERS, 2021-2028(%)
  • 8. GLOBAL GYNECOLOGICAL CANCER MARKET SHARE BY GEOGRAPHY, 2021-2028(%)
  • 9. NORTH AMERICA GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 10. UNITED STATES GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 11. CANADA GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 12. EUROPE GYNECOLOGICAL CANCER S MARKET SIZE, 2021-2028($ MILLION)
  • 13. UK GYNECOLOGICAL CANCER S MARKET SIZE, 2021-2028($ MILLION)
  • 14. FRANCE GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 15. SPAIN GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 16. GERMANY GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 17. ITALY GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 18. ROE GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 19. ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 20. INDIA GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 21. CHINA GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 22. JAPAN GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 23. REST OF ASIA-PACIFIC GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)
  • 24. REST OF THE WORLD GYNECOLOGICAL CANCER MARKET SIZE, 2021-2028($ MILLION)